ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Adverse Effects of Carbon Black Nanoparticles on Maternal and Fetal Lungs in Pregnant Mice: Insights From a Metabolomics Perspective.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Previous studies have linked prenatal exposure to carbon black nanoparticles (CBNPs), a key constituent of air pollution and tobacco smoke, to respiratory abnormalities. However, the distinct impacts of particle size on the maternal-fetal lung axis remain poorly understood. This study investigated the maternal-to-fetal lung toxicological effects and metabolic shifts following exposure to 30 nm (CBNP30) and 120 nm (CBNP120) particles using a high-dose mechanistic exposure model. In maternal lungs, histological analysis (H&E and Masson staining) revealed severe inflammatory infiltration and significant fibrotic injury for both sizes, with CBNP120 inducing more pronounced damage. Dark-field hyperspectral imaging confirmed the transplacental transfer and presence of both CBNP sizes within fetal lung tissues. Notably, fetal lungs did not display overt histological injury. However, significant elevations in oxidative stress and inflammatory markers (mRNA and protein) were observed, indicating clear molecular perturbation. Chemical Isotope Labeling LC-MS further identified size-specific metabolic disruption, with CBNP120 eliciting more extensive changes in the fetal metabolome. Specifically, CBNP30 primarily affected histidine metabolism in both maternal and fetal lungs, whereas CBNP120 disrupted butanoate and arachidonic acid pathways. These metabolic shifts, supported by altered enzyme expression, suggest that profound biochemical disturbances may occur in the fetus even in the absence of observable morphological damage. This study clarifies the distinction between maternal structural injury and fetal molecular dysfunction, providing critical insights for interventions against air pollution-related neonatal health risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.